<?xml version="1.0" encoding="UTF-8"?>
 <rdf:RDF xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:cc="http://web.resource.org/cc/" xmlns:syn="http://purl.org/rss/1.0/modules/syndication/" xmlns:admin="http://webns.net/mvcb/">
  <channel rdf:about="http://pinboard.in">
    <title>Pinboard (Michael.Massing)</title>
    <link>https://pinboard.in/u:Michael.Massing/public/</link>
    <description>recent bookmarks from Michael.Massing</description>
    <items>
      <rdf:Seq>	<rdf:li rdf:resource="https://9to5mac.com/2023/11/14/withings-launches-body-pro-2-diabetes-detection/"/>
	<rdf:li rdf:resource="https://www.niddk.nih.gov/about-niddk/strategic-plans-reports/diabetes-in-america-3rd-edition"/>
	<rdf:li rdf:resource="https://www.accu-chek.com/life/travel-diabetes?XID=1d19e6c78182f10864a3d943549b47b8528e444a2c41692c190590232fbd7468&amp;contactid=003b0000011F9YsAAK"/>
	<rdf:li rdf:resource="https://www.google.com/search?client=safari&amp;rls=en&amp;q=%22Prediabetic%22+was+a+negotiated+label+for+failing+a+one+of+two+oral+glucose+tolerance+tests#ip=1"/>
	<rdf:li rdf:resource="https://medicalxpress.com/news/2023-04-diabetes.html"/>
	<rdf:li rdf:resource="https://newatlas.com/medical/sugar-powered-implant-diabetes/"/>
	<rdf:li rdf:resource="https://www.sflorg.com/2023/03/bio03282302.html"/>
	<rdf:li rdf:resource="https://www.statnews.com/2023/03/24/diabetes-screening-age-weight-asian-americans/"/>
	<rdf:li rdf:resource="https://pinboard.in/add?next=same&amp;url=https%25253A%25252F%25252Fwww.statnews.com%25252F2023%25252F03%25252F24%25252Fdiabetes-screening-age-weight-asian-americans%25252F%25253Futm_medium%25253Dsocial%252526utm_source%25253Dmastodon%252526utm_campaign%25253Dmastodon_organic&amp;description=&amp;title=Screening%252520for%252520diabetes%252520according%252520to%252520age%25252C%252520not%252520weight%252520-%252520STAT"/>
	<rdf:li rdf:resource="https://www.levelshealth.com/blog/do-you-get-enough-zinc-heres-how-it-benefits-metabolic-health"/>
	<rdf:li rdf:resource="https://www.rush.edu/news/understanding-link-between-covid-19-and-diabetes"/>
	<rdf:li rdf:resource="https://www.diabetesselfmanagement.com/news-research/2022/12/14/a1c-testing-may-help-detect-undiagnosed-diabetes/"/>
	<rdf:li rdf:resource="https://twitter.com/katiegibbs/status/1601688909146005504"/>
	<rdf:li rdf:resource="https://diatribe.org/is-your-pancreas-responsible-for-your-diabetes"/>
	<rdf:li rdf:resource="https://twitter.com/AndreaLimbourg/status/1519696074012778496"/>
	<rdf:li rdf:resource="https://twitter.com/PaleoGranny58/status/1519313863144996864"/>
	<rdf:li rdf:resource="https://twitter.com/diabetesalish/status/1519370059365367816/photo/1"/>
	<rdf:li rdf:resource="https://www.diabetes-m.com/blog/tips-tricks/handling-diabetes-and-everything-that-comes-with-the-holiday-season/"/>
	<rdf:li rdf:resource="https://academic.oup.com/eurjpc/advance-article/doi/10.1093/eurjpc/zwab189/6447088"/>
	<rdf:li rdf:resource="https://www.diabetesresearchclinicalpractice.com/action/showPdf?pii=S0168-8227%2821%2900008-5"/>
	<rdf:li rdf:resource="https://extranet.who.int/dataformv3/index.php/431538?lang=en"/>
	<rdf:li rdf:resource="https://www.google.com/search?q=type+2+diabetes+exercise+diet+behavioral+treatment+twitter+facebook&amp;newwindow=1&amp;client=safari&amp;rls=en&amp;sxsrf=AOaemvJP8n-9pMVVKl8UWhc_Oq9V6jA25w:1632880155607&amp;source=lnt&amp;tbs=qdr:y&amp;sa=X&amp;ved=2ahUKEwiQsorNiKPzAhUmnOAKHUsqDmEQpwV6BAgBECU&amp;biw=1679&amp;bih=937&amp;dpr=1"/>
	<rdf:li rdf:resource="https://www.google.com/search?q=type+2+diabetes+exercise+diet+behavioral+treatment&amp;newwindow=1&amp;client=safari&amp;rls=en&amp;biw=1679&amp;bih=937&amp;tbs=qdr%3Ay&amp;sxsrf=AOaemvLSEMUhKSS-RePJy1EjDwdeSvNygA%3A1632881840128&amp;ei=sMxTYYaGB-OyggeD7Z-4Aw&amp;oq=type+2+diabetes+exercise+diet+behavioral+treatment&amp;gs_lcp=Cgdnd3Mtd2l6EAMyBAgjECcyBAgjECc6BwgjELADECc6BwgAEEcQsANKBAhBGABQzo4BWOqSAWC8mwFoAnACeACAAWKIAb8BkgEBMpgBAKABAcgBCcABAQ&amp;sclient=gws-wiz&amp;ved=0ahUKEwiGnqnwjqPzAhVjmeAKHYP2BzcQ4dUDCA0&amp;uact=5"/>
	<rdf:li rdf:resource="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4704936/"/>
	<rdf:li rdf:resource="https://twitter.com/DPSCatUPITT"/>
	<rdf:li rdf:resource="https://www.diabetes.org/diabetes/type-2/living-with-type-2-diabetes-program"/>
	<rdf:li rdf:resource="https://www.cdc.gov/diabetes/prevention/about.htm"/>
	<rdf:li rdf:resource="https://www.cdc.gov/diabetes/prevention/find-a-program.html"/>
	<rdf:li rdf:resource="https://diabetes.org/ask-the-experts"/>
	<rdf:li rdf:resource="https://www.healthline.com/health/type-2-diabetes/online-support-for-type-2-diabetes#forums"/>
	<rdf:li rdf:resource="https://www.everydayhealth.com/columns/my-health-story/how-peer-support-transformed-my-type-2-diabetes-management/"/>
	<rdf:li rdf:resource="https://www.healthline.com/type-2-diabetes"/>
	<rdf:li rdf:resource="https://www.diabeteseducator.org/"/>
	<rdf:li rdf:resource="https://jillweisenberger.com/meet-jill/"/>
	<rdf:li rdf:resource="https://www.google.com/search?client=safari&amp;rls=en&amp;q=jill+weisenberger&amp;ie=UTF-8&amp;oe=UTF-8"/>
	<rdf:li rdf:resource="https://twitter.com/MiriamETucker/status/1433097008458440714?s=20"/>
	<rdf:li rdf:resource="https://community.beyondtype2.org/"/>
	<rdf:li rdf:resource="https://www.diabetesdaily.com/forum/"/>
	<rdf:li rdf:resource="https://forum.tudiabetes.org/"/>
	<rdf:li rdf:resource="https://www.diabetesprevention.pitt.edu/for-the-public/diabetes-prevention-program-dpp/"/>
	<rdf:li rdf:resource="https://www.medscape.com/viewarticle/957955#vp_1"/>
	<rdf:li rdf:resource="https://www.endocrinologyadvisor.com/home/topics/diabetes/type-2-diabetes/weight-loss-and-cardiovascular-renal-benefit-with-sglt2-inhibitors-in-t2d/?hmSubId=YY-zPItNrOw1&amp;hmEmail=Jw_YJjhVyI84iX-Oepu7iw7YiNSIB0EK31LP7LVx8w01&amp;NID=-1&amp;email_hash=983917dd1eba78eb44e393fea65df5ca&amp;mpweb=1323-149900-7624403"/>
	<rdf:li rdf:resource="https://www.sciencedaily.com/releases/2010/06/100608182645.htm"/>
	<rdf:li rdf:resource="https://www.diabetes.org/a1c/diagnosis"/>
	<rdf:li rdf:resource="https://www.mayoclinic.org/diseases-conditions/diabetes/diagnosis-treatment/drc-20371451"/>
	<rdf:li rdf:resource="https://diabeteswise.org/check-up/#/"/>
	<rdf:li rdf:resource="https://twitter.com/Type2andYouCDE/status/1204404950194950144/photo/1"/>
	<rdf:li rdf:resource="http://twicediabetes.com/cheating-lies-hcps-tell/#more-72"/>
	<rdf:li rdf:resource="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/217393"/>
	<rdf:li rdf:resource="https://www.cdc.gov/mmwr/volumes/67/wr/mm6712a3.htm"/>
	<rdf:li rdf:resource="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357617/"/>
	<rdf:li rdf:resource="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3215499/"/>
	<rdf:li rdf:resource="https://link.springer.com/article/10.1007/s00125-012-2690-2"/>
	<rdf:li rdf:resource="https://care.diabetesjournals.org/content/43/1/117"/>
	<rdf:li rdf:resource="http://macrofour.com/the-cure-for-diabetes-delivered"/>
	<rdf:li rdf:resource="https://link.springer.com/article/10.1007/s00125-020-05253-x#Sec4"/>
	<rdf:li rdf:resource="https://care.diabetesjournals.org/content/28/11/2756"/>
	<rdf:li rdf:resource="https://www.pbs.org/wgbh/blood-sugar-rising/home/watch/"/>
	<rdf:li rdf:resource="https://professional.diabetes.org/content-page/practice-guidelines-resources"/>
	<rdf:li rdf:resource="https://www.diabetesselfmanagement.com/blog/vitamin-d-pills-type-2-diabetes-progression-study/"/>
	<rdf:li rdf:resource="https://www.cdc.gov/diabetes/programs/stateandlocal/resources/dsmes-technical-assistance-guide.html"/>
	<rdf:li rdf:resource="https://www.diabeteseducator.org/practice/practice-documents/national-standards-for-dsmes"/>
	<rdf:li rdf:resource="https://scienceblogs.com/deanscorner/2011/03/09/diabetes-belt-fast-food-belt"/>
	<rdf:li rdf:resource="https://twitter.com/fallabel/status/1271546651031658496?s=12"/>
	<rdf:li rdf:resource="https://sugarbeat.com/"/>
	<rdf:li rdf:resource="https://www.medpagetoday.com/endocrinology/type1diabetes/82755?xid=nl_mpt_DHE_2019-10-16&amp;eun=g894600d0r"/>
	<rdf:li rdf:resource="https://well.blogs.nytimes.com/2013/07/12/blaming-the-patient-then-asking-forgiveness/"/>
	<rdf:li rdf:resource="https://sternspeakers.com/news/happens-experts-err-dr-peter-attias-ted-talk-goes-viral-find/"/>
	<rdf:li rdf:resource="https://www.bmj.com/content/368/bmj.l6775/rapid-responses"/>
	<rdf:li rdf:resource="https://www.nature.com/articles/ejcn201539/"/>
      </rdf:Seq>
    </items>
  </channel><item rdf:about="https://9to5mac.com/2023/11/14/withings-launches-body-pro-2-diabetes-detection/">
    <title>Withings launches Body Pro 2 cellular scale with early diabetes complication detection - 9to5Mac</title>
    <dc:date>2023-11-15T20:21:39+00:00</dc:date>
    <link>https://9to5mac.com/2023/11/14/withings-launches-body-pro-2-diabetes-detection/</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>health gadgets devices monitor risk diabetes diabetic complications scale feet</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:e9ce0051cdc1/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:health"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:gadgets"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:devices"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:monitor"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:risk"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetic"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:complications"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:scale"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:feet"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.niddk.nih.gov/about-niddk/strategic-plans-reports/diabetes-in-america-3rd-edition">
    <title>Diabetes in America, 3rd Edition - NIDDK</title>
    <dc:date>2023-06-21T06:49:32+00:00</dc:date>
    <link>https://www.niddk.nih.gov/about-niddk/strategic-plans-reports/diabetes-in-america-3rd-edition</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>insulin type 2 diabetes T2D treatment exogenous medication</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:6f6759132d19/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:insulin"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:2"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T2D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:treatment"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:exogenous"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:medication"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.accu-chek.com/life/travel-diabetes?XID=1d19e6c78182f10864a3d943549b47b8528e444a2c41692c190590232fbd7468&amp;contactid=003b0000011F9YsAAK">
    <title>Travel with diabetes | Accu-Chek</title>
    <dc:date>2023-06-20T19:06:17+00:00</dc:date>
    <link>https://www.accu-chek.com/life/travel-diabetes?XID=1d19e6c78182f10864a3d943549b47b8528e444a2c41692c190590232fbd7468&amp;contactid=003b0000011F9YsAAK</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>diabetes travel</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:4159e315e9c0/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:travel"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.google.com/search?client=safari&amp;rls=en&amp;q=%22Prediabetic%22+was+a+negotiated+label+for+failing+a+one+of+two+oral+glucose+tolerance+tests#ip=1">
    <title>&quot;Prediabetic&quot; was a negotiated label for failing a one of two oral glucose tolerance tests - Google Search</title>
    <dc:date>2023-04-29T18:28:09+00:00</dc:date>
    <link>https://www.google.com/search?client=safari&amp;rls=en&amp;q=%22Prediabetic%22+was+a+negotiated+label+for+failing+a+one+of+two+oral+glucose+tolerance+tests#ip=1</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>diabetes type 2 T2D diagnosis threshold morbidity mortality comorbidity risk overview criticism standard</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:7e811b2f162f/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:2"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T2D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diagnosis"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:threshold"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:morbidity"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:mortality"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:comorbidity"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:risk"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:overview"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:criticism"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:standard"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://medicalxpress.com/news/2023-04-diabetes.html">
    <title>New test could help identify type 2 diabetes risk</title>
    <dc:date>2023-04-07T22:15:39+00:00</dc:date>
    <link>https://medicalxpress.com/news/2023-04-diabetes.html</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>diabetes type 2 research peer-reviewed human in vivo clinical situ screening prevention delay risk factor</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:a1b2761cabcb/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:2"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:peer-reviewed"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:human"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:in"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:vivo"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:clinical"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:situ"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:screening"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:prevention"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:delay"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:risk"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:factor"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://newatlas.com/medical/sugar-powered-implant-diabetes/">
    <title>Sugar-powered teabag-like implant successfully manages type 1 diabetes</title>
    <dc:date>2023-03-31T03:46:37+00:00</dc:date>
    <link>https://newatlas.com/medical/sugar-powered-implant-diabetes/</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>diabetes technology battery closed loop artificial beta cells control mechanism experimental peer-reviewed research in vivo animal mouse models</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:3cfe9d76082d/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:technology"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:battery"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:closed"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:loop"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:artificial"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:beta"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:cells"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:control"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:mechanism"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:experimental"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:peer-reviewed"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:in"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:vivo"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:animal"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:mouse"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:models"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.sflorg.com/2023/03/bio03282302.html">
    <title>Scientific Frontline: Adipose tissue as a culprit: How obesity leads to diabetes</title>
    <dc:date>2023-03-28T21:50:07+00:00</dc:date>
    <link>https://www.sflorg.com/2023/03/bio03282302.html</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>type 2 diabetes T2D insulin resistance fat dietary adipose tissue pathophysiology risk factor etiology diet behavior behavioral environment environmental obesity endocrine body</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:77e14458fb43/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:2"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T2D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:insulin"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:resistance"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:fat"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:dietary"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:adipose"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:tissue"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:pathophysiology"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:risk"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:factor"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:etiology"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diet"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:behavior"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:behavioral"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:environment"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:environmental"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:obesity"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:endocrine"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:body"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.statnews.com/2023/03/24/diabetes-screening-age-weight-asian-americans/">
    <title>Screening for diabetes according to age, not weight - STAT</title>
    <dc:date>2023-03-26T21:24:35+00:00</dc:date>
    <link>https://www.statnews.com/2023/03/24/diabetes-screening-age-weight-asian-americans/</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[Looking at a national survey that recorded people’s blood sugar levels, the researchers found that the new guidelines do detect a greater share of people with people with prediabetes or diabetes. However, the percentage of cases identified among Asian people is significantly lower than for other racial and ethnic groups.

The researchers then looked at the amount of cases that would be identified if all adults ages 35-70, regardless of BMI, were screened. That criteria detects more cases within the broad population and more equal percentages of diabetes cases across racial groups.]]></description>
<dc:subject>diabetes type 2 screening criteria age weight BMI ethnicity peer-reviewed research human retrospective cohort statistical</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:661e9e583593/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:2"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:screening"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:criteria"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:age"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:weight"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:BMI"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:ethnicity"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:peer-reviewed"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:human"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:retrospective"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:cohort"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:statistical"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://pinboard.in/add?next=same&amp;url=https%25253A%25252F%25252Fwww.statnews.com%25252F2023%25252F03%25252F24%25252Fdiabetes-screening-age-weight-asian-americans%25252F%25253Futm_medium%25253Dsocial%252526utm_source%25253Dmastodon%252526utm_campaign%25253Dmastodon_organic&amp;description=&amp;title=Screening%252520for%252520diabetes%252520according%252520to%252520age%25252C%252520not%252520weight%252520-%252520STAT">
    <title>Pinboard - Save a Bookmark</title>
    <dc:date>2023-03-26T21:24:12+00:00</dc:date>
    <link>https://pinboard.in/add?next=same&amp;url=https%25253A%25252F%25252Fwww.statnews.com%25252F2023%25252F03%25252F24%25252Fdiabetes-screening-age-weight-asian-americans%25252F%25253Futm_medium%25253Dsocial%252526utm_source%25253Dmastodon%252526utm_campaign%25253Dmastodon_organic&amp;description=&amp;title=Screening%252520for%252520diabetes%252520according%252520to%252520age%25252C%252520not%252520weight%252520-%252520STAT</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>diabetes type 2 screening criteria age weight BMI ethnicity peer-reviewed research human retrospective cohort statistical</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:1ef73bbde2a7/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:2"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:screening"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:criteria"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:age"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:weight"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:BMI"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:ethnicity"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:peer-reviewed"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:human"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:retrospective"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:cohort"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:statistical"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.levelshealth.com/blog/do-you-get-enough-zinc-heres-how-it-benefits-metabolic-health">
    <title>Do you get enough zinc? Here’s how it benefits metabolic health - Levels</title>
    <dc:date>2023-03-24T15:02:04+00:00</dc:date>
    <link>https://www.levelshealth.com/blog/do-you-get-enough-zinc-heres-how-it-benefits-metabolic-health</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[According to the National Institutes of Health, the daily zinc requirements are:
Men, age 19+: 11 milligrams (mg)
Women, age 19+: 8 mg (11 mg if pregnant)
You can supplement with more zinc than the RDA since the RDA represents the minimum required amount of zinc, which may be lower than optimal zinc levels, mainly due to large-scale factors that put the general population at higher risk for zinc deficiency. Mark Hyman, MD, a Levels Advisor and best-selling author, recommends taking 30 mg daily for men and women.
The general guidance for the upper limit for zinc intake is 40 mg daily since excessive zinc intake can cause symptoms such as nausea, dizziness, headaches, and loss of appetite and is associated with high blood pressure, reduced immune function, and lower HDL cholesterol levels. Studies have also shown that very high doses of zinc from supplements (142 mg/day) may interfere with magnesium and copper absorption.]]></description>
<dc:subject>T2D pancreas beta cells wound healing zinc dosage overview risk benefit systemic effects diabetes type 2 interactions food sources blood levels</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:9be1798c8cda/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T2D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:pancreas"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:beta"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:cells"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:wound"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:healing"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:zinc"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:dosage"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:overview"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:risk"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:benefit"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:systemic"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:effects"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:2"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:interactions"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:food"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:sources"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:blood"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:levels"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.rush.edu/news/understanding-link-between-covid-19-and-diabetes">
    <title>Understanding the Link Between COVID-19 and Diabetes | Rush System</title>
    <dc:date>2023-01-10T17:15:30+00:00</dc:date>
    <link>https://www.rush.edu/news/understanding-link-between-covid-19-and-diabetes</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[Scientists already know that for some people, it’s not just a faulty immune system that triggers type 1 diabetes or insulin resistance that leads to type 2 diabetes. The National Institute of Diabetes, Digestive and Kidney Diseases recognizes more than 50 different ways that a person can develop diabetes, from defects in a single gene to other health issues like liver disease.

“Ideally, we would like to investigate each and every one of those 50 causes,” Kazlauskaite says. “And we are finding that some people have several diabetes causes at the same time. In other words, a patient may not just have the purely insulin-resistant type of diabetes, what’s typically defined as type 2, but they might also be affected by steroids or autoimmune diabetes at the same time.” Doctors may call this “hybrid diabetes,” suggesting that the etiology, or cause, of diabetes may be much more complex than originally believed.

Could COVID-19 be a new cause of diabetes?
It’s possible, Kazlauskaite says. A study recently published in the medical journal Lancet found that people who survived COVID have a 40% higher risk for developing diabetes. She believes many of the new cases of type 2 diabetes are occurring in people with pre-diabetes who don’t know it.

“People might have pre-diabetes with chronic, subclinical inflammation before they get COVID-19. So, when they do get infected with the virus, they could develop hyperinflammation that causes metabolic stress and more insulin resistance. As a result, they manifest overt diabetes,” she says.

Another theory is that COVID-19 disrupts the immune system. “We know hyperinflammation can cause autoimmune disease. When this happens, the immune system gets ‘confused’ and starts attacking its own tissues, including insulin-producing cells in the pancreas,” she says. This is the process that causes type 1 diabetes, which primarily develops in childhood but may also affect adults.

A third theory is that steroids given during COVID-19 treatment could cause diabetes because they often raise blood glucose, Kazlauskaite says. For some patients, glucose levels return to normal after the steroids have been discontinued, but for others, the effects are lasting.

A fourth reported hypothesis is that COVID-19 can cause severe inflammation of the pancreas (known as pancreatitis), where the body’s insulin-producing cells reside. This can trigger diabetes, although it is relatively rare]]></description>
<dc:subject>diabetes etiology cause risk factors type 1 2 T1D T2D autoimmune hyperinflammation prediabetes inflammation subclinical overview resarch long COVID post-acute sequelae liver hybrid insulin resistance immune system steroids pancreatitis pancreas metabolic stress</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:6fbe3726f6ad/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:etiology"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:cause"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:risk"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:factors"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:1"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:2"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T1D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T2D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:autoimmune"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:hyperinflammation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:prediabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:inflammation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:subclinical"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:overview"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:resarch"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:long"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:COVID"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:post-acute"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:sequelae"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:liver"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:hybrid"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:insulin"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:resistance"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:immune"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:system"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:steroids"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:pancreatitis"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:pancreas"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:metabolic"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:stress"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.diabetesselfmanagement.com/news-research/2022/12/14/a1c-testing-may-help-detect-undiagnosed-diabetes/">
    <title>A1C Testing May Help Detect Undiagnosed Diabetes - DSM</title>
    <dc:date>2022-12-20T19:50:31+00:00</dc:date>
    <link>https://www.diabetesselfmanagement.com/news-research/2022/12/14/a1c-testing-may-help-detect-undiagnosed-diabetes/</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA["The researchers also found that using just age or body-mass index (BMI) to decide who should get screening for diabetes — and receive an A1C test — would miss more than 40% of undiagnosed diabetes cases."
[Validated risk scores] did better, with the ADA Risk Score missing 23.3% of undiagnosed diabetes cases, the Leicester Risk Score missing 15.7% of undiagnosed cases, and the Finnish Diabetes Risk Score missing 7.8%...when the lowest potential cutoff score was used.]]></description>
<dc:subject>diabetes diagnosis screening A1c BMI age risk validated score undiagnosed</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:9c5a8ebc62b3/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diagnosis"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:screening"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:A1c"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:BMI"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:age"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:risk"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:validated"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:score"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:undiagnosed"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://twitter.com/katiegibbs/status/1601688909146005504">
    <title>(400) https://twitter.com/katiegibbs/status/1601688909146005504</title>
    <dc:date>2022-12-11T03:24:43+00:00</dc:date>
    <link>https://twitter.com/katiegibbs/status/1601688909146005504</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[RT @MiriamETucker: If a biodiversity conference can still do this, you would THINK that meetings of clinicians who care for people with chronic high-risk medical conditions including #diabetes might. But at the five I've attended in 2022, not even close. ]]></description>
<dc:subject>diabetes</dc:subject>
<dc:source>https://twitter.com/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:f9286e5fe465/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://diatribe.org/is-your-pancreas-responsible-for-your-diabetes">
    <title>Is Your Pancreas Responsible for Your Diabetes?</title>
    <dc:date>2022-08-11T19:09:00+00:00</dc:date>
    <link>https://diatribe.org/is-your-pancreas-responsible-for-your-diabetes</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[For people with type 1 diabetes, the body’s immune system attacks the cells in the islets of Langerhans, including beta cells. This means that the body is no longer able to produce insulin or regulate glucose levels.

The problem for individuals with type 1 diabetes is that excessive hunger and thirst causes blood glucose levels to increase. There are no hormones being secreted to tell the body to begin using this glucose for energy or storage. 

Even without a properly functioning endocrine pancreas, the exocrine pancreas can still function as it is supposed to. The exocrine pancreas will help the stomach break down food into components to be absorbed into the blood. But without insulin, this results in high blood glucose levels, which can damage other organs like the kidneys, nerves, eyes, and heart. 

In those with type 2 diabetes, the issue is slightly different. The pancreas still secretes some, but not enough, insulin. In addition, the body’s cells cannot properly use the insulin being made. This is called insulin resistance. This also leads to blood glucose levels that are higher than they should be. 

However, many medications and other interventions can help people manage their type 2 diabetes and lower glucose levels into a healthy range. These interventions include insulin (the medication), other diabetes medications like metformin, SGLT-2 inhibitors, and GLP-1 receptor agonists, and lifestyle modifications that focus on eating less and exercising more.]]></description>
<dc:subject>diabetes type 1 2 T1D T2D insulin production resistance pancreas sufficiency function</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:56821474fef8/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:1"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:2"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T1D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T2D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:insulin"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:production"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:resistance"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:pancreas"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:sufficiency"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:function"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://twitter.com/AndreaLimbourg/status/1519696074012778496">
    <title>(400) https://twitter.com/AndreaLimbourg/status/1519696074012778496</title>
    <dc:date>2022-04-28T21:36:29+00:00</dc:date>
    <link>https://twitter.com/AndreaLimbourg/status/1519696074012778496</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[RT @type2musings: What matters to you? How do you define quality of life? 
#ATTD2022 #QoL #diabetes ]]></description>
<dc:subject>QoL diabetes ATTD2022</dc:subject>
<dc:source>https://twitter.com/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:1b8ecc591a4e/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:QoL"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:ATTD2022"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://twitter.com/PaleoGranny58/status/1519313863144996864">
    <title>(400) https://twitter.com/PaleoGranny58/status/1519313863144996864</title>
    <dc:date>2022-04-27T17:50:16+00:00</dc:date>
    <link>https://twitter.com/PaleoGranny58/status/1519313863144996864</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[RT @diabetesalish: WRONG. 
cc: #diabetes #doc #dsma peeps - do your thing!  ]]></description>
<dc:subject>doc dsma diabetes</dc:subject>
<dc:source>https://twitter.com/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:e63d5bc0e54f/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:doc"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:dsma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://twitter.com/diabetesalish/status/1519370059365367816/photo/1">
    <title>(400) https://twitter.com/diabetesalish/status/1519370059365367816/photo/1</title>
    <dc:date>2022-04-27T17:50:16+00:00</dc:date>
    <link>https://twitter.com/diabetesalish/status/1519370059365367816/photo/1</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[RT @diabetesalish: WRONG. 
cc: #diabetes #doc #dsma peeps - do your thing!  ]]></description>
<dc:subject>doc dsma diabetes</dc:subject>
<dc:source>https://twitter.com/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:c04e58dd438a/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:doc"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:dsma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.diabetes-m.com/blog/tips-tricks/handling-diabetes-and-everything-that-comes-with-the-holiday-season/">
    <title>Handling Diabetes and Everything that Comes with the Holiday Season! – Diabetes:M – Your Diabetes Management App</title>
    <dc:date>2021-12-29T04:40:05+00:00</dc:date>
    <link>https://www.diabetes-m.com/blog/tips-tricks/handling-diabetes-and-everything-that-comes-with-the-holiday-season/</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>diabetes food holidays coping stress management</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:de367b00cda6/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:food"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:holidays"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:coping"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:stress"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:management"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://academic.oup.com/eurjpc/advance-article/doi/10.1093/eurjpc/zwab189/6447088">
    <title>Sodium glucose co-transporter 2 inhibitors in heart failure with preserved ejection fraction: a systematic review and meta-analysis | European Journal of Preventive Cardiology | Oxford Academic</title>
    <dc:date>2021-12-16T03:23:08+00:00</dc:date>
    <link>https://academic.oup.com/eurjpc/advance-article/doi/10.1093/eurjpc/zwab189/6447088</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[We confirm that the use of SGLT2i is associated with a substantial decrease in the risk of CV death or HHF in patients with heart failure and ejection fraction >40%. Importantly, in this first and largest meta-analysis reviewing LVEF >50%, we show that this benefit is maintained, albeit to a lesser degree, in the cohort of patients with LVEF ≥50%. SGLT2i become in this way the first medication with potential for prognostic benefit in HFpEF. However, overall mortality was not improved in HFpEF, indicating that the other comorbidities associated with HFpEF play a significant role. In order to draw robust conclusions safely regarding these efficacy outcomes, further large trials need to evaluate the effect of the SGLT2 inhibitors in a sufficient number of patients with HFpEF.

The various subphenotypes of HFpEF and its management have puzzled physicians for several years. The high rates of morbidity and mortality that it carries, along with the diagnostic and treatment challenges, have transformed it in one of the most challenging clinical entities. SGLT2i appear to provide some light and positivity, as their cardiometabolic profile impacts favourably on the complex pathophysiological mechanisms involved in HFpEF.9 However, the quest to untangle the complexity of treating HFpEF is certainly not over. We show conclusively that for LVEF 40–50% included as HFpEF in previous studies (but no longer considered HFpEF in the guidelines) there is a strong benefit from SGLT2i translating to reduced cardiovascular mortality and HHF, but not overall mortality. This also extended to the LVEF >50% but with a smaller effect. Additionally, while the vast majority of the patients included in this meta-analysis were individuals with diabetes at baseline, the cardioprotective benefits of the SGLT2i have been shown to occur via mechanisms independent of baseline diabetes status.10 Furthermore, the effect of SGLT2i in patients with reduced EF without diabetes is well-documented9,10 and EMPEROR-Preserved also included patients without diabetes, therefore their effect is applicable to patients without diabetes.]]></description>
<dc:subject>SGLT2 inhibitor risk benefit heart failure ejection fraction meta-analysis diabetes comorbidity cardiac cardiovascular protection peer-reviewed research</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:c3be4a0be53b/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:SGLT2"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:inhibitor"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:risk"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:benefit"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:heart"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:failure"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:ejection"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:fraction"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:meta-analysis"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:comorbidity"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:cardiac"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:cardiovascular"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:protection"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:peer-reviewed"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.diabetesresearchclinicalpractice.com/action/showPdf?pii=S0168-8227%2821%2900008-5">
    <title>Our language matters</title>
    <dc:date>2021-10-25T04:17:24+00:00</dc:date>
    <link>https://www.diabetesresearchclinicalpractice.com/action/showPdf?pii=S0168-8227%2821%2900008-5</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[Our language matters: Improving communication with and about people with diabetes. A position statement by Diabetes Australia]]></description>
<dc:subject>diabetes language stigma position statement Australia clinical education bedside manner</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:1a471f05061b/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:language"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:stigma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:position"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:statement"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Australia"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:clinical"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:education"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:bedside"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:manner"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://extranet.who.int/dataformv3/index.php/431538?lang=en">
    <title>Application for Membership - WHO Global Diabetes Compact Forum</title>
    <dc:date>2021-10-20T01:25:22+00:00</dc:date>
    <link>https://extranet.who.int/dataformv3/index.php/431538?lang=en</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[RT @Jandelliott: Announcement: the @WHO is convening a Global Diabetes Compact Forum - a global collection of diabetes stakeholders. Details below. Organizations are welcomed to apply here:
 #NCDs #T1D #T2D #diabetes #globalhealth #insulin4all]]></description>
<dc:subject>T2D insulin4all T1D globalhealth diabetes NCDs</dc:subject>
<dc:source>https://twitter.com/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:936e68c9240e/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T2D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:insulin4all"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T1D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:globalhealth"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:NCDs"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.google.com/search?q=type+2+diabetes+exercise+diet+behavioral+treatment+twitter+facebook&amp;newwindow=1&amp;client=safari&amp;rls=en&amp;sxsrf=AOaemvJP8n-9pMVVKl8UWhc_Oq9V6jA25w:1632880155607&amp;source=lnt&amp;tbs=qdr:y&amp;sa=X&amp;ved=2ahUKEwiQsorNiKPzAhUmnOAKHUsqDmEQpwV6BAgBECU&amp;biw=1679&amp;bih=937&amp;dpr=1">
    <title>type 2 diabetes exercise diet behavioral treatment twitter facebook - Google Search</title>
    <dc:date>2021-09-29T02:22:31+00:00</dc:date>
    <link>https://www.google.com/search?q=type+2+diabetes+exercise+diet+behavioral+treatment+twitter+facebook&amp;newwindow=1&amp;client=safari&amp;rls=en&amp;sxsrf=AOaemvJP8n-9pMVVKl8UWhc_Oq9V6jA25w:1632880155607&amp;source=lnt&amp;tbs=qdr:y&amp;sa=X&amp;ved=2ahUKEwiQsorNiKPzAhUmnOAKHUsqDmEQpwV6BAgBECU&amp;biw=1679&amp;bih=937&amp;dpr=1</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>diabetes type 2 T2D online community DOC research Facebook social media Twitter weight loss management behavioral in vivo situ human trial</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:84d1863038d5/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:2"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T2D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:online"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:community"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:DOC"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Facebook"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:social"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:media"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Twitter"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:weight"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:loss"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:management"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:behavioral"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:in"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:vivo"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:situ"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:human"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:trial"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.google.com/search?q=type+2+diabetes+exercise+diet+behavioral+treatment&amp;newwindow=1&amp;client=safari&amp;rls=en&amp;biw=1679&amp;bih=937&amp;tbs=qdr%3Ay&amp;sxsrf=AOaemvLSEMUhKSS-RePJy1EjDwdeSvNygA%3A1632881840128&amp;ei=sMxTYYaGB-OyggeD7Z-4Aw&amp;oq=type+2+diabetes+exercise+diet+behavioral+treatment&amp;gs_lcp=Cgdnd3Mtd2l6EAMyBAgjECcyBAgjECc6BwgjELADECc6BwgAEEcQsANKBAhBGABQzo4BWOqSAWC8mwFoAnACeACAAWKIAb8BkgEBMpgBAKABAcgBCcABAQ&amp;sclient=gws-wiz&amp;ved=0ahUKEwiGnqnwjqPzAhVjmeAKHYP2BzcQ4dUDCA0&amp;uact=5">
    <title>type 2 diabetes exercise diet behavioral treatment - Google Search</title>
    <dc:date>2021-09-29T02:19:49+00:00</dc:date>
    <link>https://www.google.com/search?q=type+2+diabetes+exercise+diet+behavioral+treatment&amp;newwindow=1&amp;client=safari&amp;rls=en&amp;biw=1679&amp;bih=937&amp;tbs=qdr%3Ay&amp;sxsrf=AOaemvLSEMUhKSS-RePJy1EjDwdeSvNygA%3A1632881840128&amp;ei=sMxTYYaGB-OyggeD7Z-4Aw&amp;oq=type+2+diabetes+exercise+diet+behavioral+treatment&amp;gs_lcp=Cgdnd3Mtd2l6EAMyBAgjECcyBAgjECc6BwgjELADECc6BwgAEEcQsANKBAhBGABQzo4BWOqSAWC8mwFoAnACeACAAWKIAb8BkgEBMpgBAKABAcgBCcABAQ&amp;sclient=gws-wiz&amp;ved=0ahUKEwiGnqnwjqPzAhVjmeAKHYP2BzcQ4dUDCA0&amp;uact=5</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>diabetes type 2 T2D online community DOC research weight loss management behavioral in vivo situ human trial peer-reviewed glucose</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:3d5d25d1a11d/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:2"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T2D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:online"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:community"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:DOC"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:weight"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:loss"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:management"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:behavioral"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:in"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:vivo"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:situ"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:human"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:trial"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:peer-reviewed"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:glucose"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4704936/">
    <title>Twitter-Delivered Behavioral Weight-Loss Interventions: A Pilot Series</title>
    <dc:date>2021-09-29T02:16:05+00:00</dc:date>
    <link>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4704936/</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>diabetes type 1 2 T1D T2D online community DOC research Twitter weight loss management behavioral in vivo situ human trial peer-reviewed</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:572714494ce9/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:1"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:2"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T1D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T2D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:online"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:community"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:DOC"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Twitter"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:weight"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:loss"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:management"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:behavioral"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:in"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:vivo"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:situ"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:human"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:trial"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:peer-reviewed"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://twitter.com/DPSCatUPITT">
    <title>DPSC (@DPSCatUPITT) / Twitter</title>
    <dc:date>2021-09-29T02:10:28+00:00</dc:date>
    <link>https://twitter.com/DPSCatUPITT</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>diabetes prevention T2D progression behavioral management diet exercise resource information education support type 2</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:bc4a9cc04419/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:prevention"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T2D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:progression"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:behavioral"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:management"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diet"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:exercise"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:resource"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:information"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:education"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:support"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:2"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.diabetes.org/diabetes/type-2/living-with-type-2-diabetes-program">
    <title>Living With Type 2 Diabetes Program | ADA</title>
    <dc:date>2021-09-29T02:09:30+00:00</dc:date>
    <link>https://www.diabetes.org/diabetes/type-2/living-with-type-2-diabetes-program</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>diabetes prevention T2D progression behavioral management diet exercise resource information education orientation ADA type 2</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:8a800d09ee19/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:prevention"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T2D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:progression"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:behavioral"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:management"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diet"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:exercise"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:resource"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:information"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:education"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:orientation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:ADA"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:2"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.cdc.gov/diabetes/prevention/about.htm">
    <title>CDC - About the Program - National Diabetes Prevention Program - Diabetes DDT</title>
    <dc:date>2021-09-29T02:07:44+00:00</dc:date>
    <link>https://www.cdc.gov/diabetes/prevention/about.htm</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>diabetes prevention progression behavioral management diet exercise</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:4c50c415e999/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:prevention"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:progression"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:behavioral"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:management"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diet"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:exercise"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.cdc.gov/diabetes/prevention/find-a-program.html">
    <title>Find a Program | Diabetes | CDC</title>
    <dc:date>2021-09-29T02:07:17+00:00</dc:date>
    <link>https://www.cdc.gov/diabetes/prevention/find-a-program.html</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>diabetes prevention progression behavioral management diet exercise</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:f94b3eadc85c/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:prevention"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:progression"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:behavioral"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:management"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diet"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:exercise"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://diabetes.org/ask-the-experts">
    <title>Ask the Experts | ADA</title>
    <dc:date>2021-09-29T02:05:31+00:00</dc:date>
    <link>https://diabetes.org/ask-the-experts</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>diabetes type 1 2 T1D T2D online community DOC forums resources research education Q&amp;A interactive experts expertise ADA</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:2a5c62018091/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:1"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:2"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T1D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T2D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:online"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:community"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:DOC"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:forums"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:resources"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:education"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Q&amp;A"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:interactive"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:experts"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:expertise"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:ADA"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.healthline.com/health/type-2-diabetes/online-support-for-type-2-diabetes#forums">
    <title>Diabetes Support Groups: Virtual, How to Find, and More</title>
    <dc:date>2021-09-29T02:02:36+00:00</dc:date>
    <link>https://www.healthline.com/health/type-2-diabetes/online-support-for-type-2-diabetes#forums</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>diabetes type 1 2 T1D T2D online community DOC forums resources research</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:c08534adbce8/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:1"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:2"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T1D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T2D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:online"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:community"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:DOC"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:forums"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:resources"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.everydayhealth.com/columns/my-health-story/how-peer-support-transformed-my-type-2-diabetes-management/">
    <title>How Peer Support Transformed My Type 2 Diabetes Management | Everyday Health</title>
    <dc:date>2021-09-29T01:51:38+00:00</dc:date>
    <link>https://www.everydayhealth.com/columns/my-health-story/how-peer-support-transformed-my-type-2-diabetes-management/</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>diabetes type 2 T2D online community DOC peer support management</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:35563c627f7b/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:2"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T2D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:online"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:community"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:DOC"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:peer"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:support"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:management"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.healthline.com/type-2-diabetes">
    <title>Type 2 Diabetes Resource Center: Symptoms, Treatments, Diet Tips</title>
    <dc:date>2021-09-29T01:49:11+00:00</dc:date>
    <link>https://www.healthline.com/type-2-diabetes</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>diabetes type 2 resources online education</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:02378b549a28/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:2"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:resources"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:online"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:education"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.diabeteseducator.org/">
    <title>Association of Diabetes Care &amp; Education Specialists</title>
    <dc:date>2021-09-29T01:47:30+00:00</dc:date>
    <link>https://www.diabeteseducator.org/</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>ADCES diabetes care education specialists</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:ede4abe1af12/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:ADCES"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:care"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:education"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:specialists"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://jillweisenberger.com/meet-jill/">
    <title>Meet Jill - NUTRITION SOLUTIONS Diabetes • Prediabetes • Heart</title>
    <dc:date>2021-09-29T01:45:51+00:00</dc:date>
    <link>https://jillweisenberger.com/meet-jill/</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>diet calorie carb carbohydrate management weight fat loss Jill Weisenberger diabetes prediabetes</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:9644c66ae122/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diet"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:calorie"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:carb"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:carbohydrate"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:management"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:weight"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:fat"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:loss"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Jill"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Weisenberger"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:prediabetes"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.google.com/search?client=safari&amp;rls=en&amp;q=jill+weisenberger&amp;ie=UTF-8&amp;oe=UTF-8">
    <title>jill weisenberger - Google Search</title>
    <dc:date>2021-09-29T01:45:02+00:00</dc:date>
    <link>https://www.google.com/search?client=safari&amp;rls=en&amp;q=jill+weisenberger&amp;ie=UTF-8&amp;oe=UTF-8</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>diet calorie carb carbohydrate management weight fat loss Jill Weisenberger diabetes</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:25198e1b5033/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diet"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:calorie"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:carb"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:carbohydrate"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:management"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:weight"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:fat"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:loss"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Jill"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Weisenberger"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://twitter.com/MiriamETucker/status/1433097008458440714?s=20">
    <title>Miriam E. Tucker on Twitter: &quot;Four major #diabetes organizations issue joint statement defining #type2diabetes &quot;remission&quot; and how to monitor individuals who achieve it. One goal is to bring the #healthcare community on the same page so the data will be m</title>
    <dc:date>2021-09-29T01:41:04+00:00</dc:date>
    <link>https://twitter.com/MiriamETucker/status/1433097008458440714?s=20</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>diabetes type 2 remission consensus research advocacy joint statemnet definition terms criteria</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:b6116d42ae7f/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:2"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:remission"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:consensus"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:advocacy"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:joint"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:statemnet"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:definition"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:terms"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:criteria"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://community.beyondtype2.org/">
    <title>ADA x BT2</title>
    <dc:date>2021-09-29T01:37:40+00:00</dc:date>
    <link>https://community.beyondtype2.org/</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>diabetes type 1 2 T1D T2D online community DOC</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:d9b06d4cf6bd/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:1"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:2"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T1D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T2D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:online"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:community"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:DOC"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.diabetesdaily.com/forum/">
    <title>Diabetes Daily Forums</title>
    <dc:date>2021-09-29T01:33:42+00:00</dc:date>
    <link>https://www.diabetesdaily.com/forum/</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>diabetes type 1 3 T1D T2D online community DOC</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:f1e4f3275a26/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:1"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:3"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T1D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T2D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:online"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:community"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:DOC"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://forum.tudiabetes.org/">
    <title>(1) TuDiabetes Forum</title>
    <dc:date>2021-09-29T01:33:19+00:00</dc:date>
    <link>https://forum.tudiabetes.org/</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>diabetes type 1 3 T1D T2D online community DOC</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:a75bce79f319/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:1"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:3"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T1D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T2D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:online"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:community"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:DOC"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.diabetesprevention.pitt.edu/for-the-public/diabetes-prevention-program-dpp/">
    <title>Diabetes Prevention Program (DPP)</title>
    <dc:date>2021-09-16T22:50:01+00:00</dc:date>
    <link>https://www.diabetesprevention.pitt.edu/for-the-public/diabetes-prevention-program-dpp/</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[The DPP’s striking results tell us that diet, exercise, and behavior modification, delays and may prevent the development of type 2 diabetes. The DPP also suggests that Metformin is effective in delaying (or preventing) the onset of diabetes.

Participants in the lifestyle intervention group–those receiving intensive counseling on effective diet, exercise, and behavior modification–reduced their risk of developing diabetes by 58%. This finding was true across all participating ethnic groups and for both men and women. Lifestyle changes worked particularly well for participants aged 60 and older, reducing their risk by 71%. About 5% of the lifestyle intervention group developed diabetes each year during the study period, compared with 11% in those who did not get the intervention. Researchers think that weight loss–achieved through better eating habits and exercise–reduces the risk of diabetes by improving the body’s ability to use insulin and process glucose.

Participants taking Metformin reduced their risk of developing diabetes by 31%. Metformin was effective for both men and women, but it was less effective in people aged 45 and older. Metformin was most effective in people 25 to 44 years old and in those with a body mass index of 35 or higher (at least 60 pounds overweight). About 7.8% of the Metformin group developed diabetes each year during the study, compared with 11% of the group receiving the placebo.

NIH Publication No. 06–5099
August 2006]]></description>
<dc:subject>diabetes type 2 T2D prevention intervention behavioral diet exercise activity weight fat loss body risk factors in vivo human clinical trial situ support treatment progression management resource information education</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:a3fdd5e0649f/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:2"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T2D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:prevention"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:intervention"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:behavioral"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diet"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:exercise"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:activity"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:weight"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:fat"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:loss"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:body"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:risk"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:factors"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:in"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:vivo"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:human"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:clinical"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:trial"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:situ"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:support"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:treatment"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:progression"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:management"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:resource"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:information"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:education"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.medscape.com/viewarticle/957955#vp_1">
    <title>Type 2 Diabetes 'Remission' Is a Reality, Say Major Organizations</title>
    <dc:date>2021-09-13T02:48:02+00:00</dc:date>
    <link>https://www.medscape.com/viewarticle/957955#vp_1</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>diabetes remission consensus definition 2021 type 2 T2D</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:85c830664d4d/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:remission"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:consensus"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:definition"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:2021"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:2"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T2D"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.endocrinologyadvisor.com/home/topics/diabetes/type-2-diabetes/weight-loss-and-cardiovascular-renal-benefit-with-sglt2-inhibitors-in-t2d/?hmSubId=YY-zPItNrOw1&amp;hmEmail=Jw_YJjhVyI84iX-Oepu7iw7YiNSIB0EK31LP7LVx8w01&amp;NID=-1&amp;email_hash=983917dd1eba78eb44e393fea65df5ca&amp;mpweb=1323-149900-7624403">
    <title>SGLT2 Inhibitors Lead to Favorable Renal, CV Outcomes in Type 2 Diabetes - Endocrinology Advisor</title>
    <dc:date>2021-08-25T17:28:16+00:00</dc:date>
    <link>https://www.endocrinologyadvisor.com/home/topics/diabetes/type-2-diabetes/weight-loss-and-cardiovascular-renal-benefit-with-sglt2-inhibitors-in-t2d/?hmSubId=YY-zPItNrOw1&amp;hmEmail=Jw_YJjhVyI84iX-Oepu7iw7YiNSIB0EK31LP7LVx8w01&amp;NID=-1&amp;email_hash=983917dd1eba78eb44e393fea65df5ca&amp;mpweb=1323-149900-7624403</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[There was a “possible benefit” for SGLT2 inhibitors in regard to major adverse CV events across 4 systematic reviews (OR/HR range, 0.80-0.89). In contrast, SGLT2 inhibitors featured “clear evidence of no effect or equivalence” for stroke and fractures. Also, there was a “clear evidence of harm” with SGLT2 inhibitors for genital infections (RR/OR range, 2.06-5.25) and ketoacidosis (HR/OR range, 1.36-2.20).]]></description>
<dc:subject>SGLT2 inhibitors peer-reviewed research human clinical trial review in vivo situ risk benefit diabetes treatment T2D type 2 kidney heart cardiovascular CVD genital infection necrosis diabetic ketoacidosis DKA</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:253b12fb0e87/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:SGLT2"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:inhibitors"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:peer-reviewed"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:human"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:clinical"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:trial"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:review"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:in"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:vivo"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:situ"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:risk"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:benefit"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:treatment"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T2D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:2"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:kidney"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:heart"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:cardiovascular"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:CVD"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:genital"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:infection"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:necrosis"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetic"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:ketoacidosis"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:DKA"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.sciencedaily.com/releases/2010/06/100608182645.htm">
    <title>Molecular link between diabetes and schizophrenia connects food and mood -- ScienceDaily</title>
    <dc:date>2021-07-15T04:47:25+00:00</dc:date>
    <link>https://www.sciencedaily.com/releases/2010/06/100608182645.htm</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[June 9, 2010
Source:
Vanderbilt University Medical Center
Summary:
Defects in insulin function -- which occur in diabetes and obesity -- could directly contribute to psychiatric disorders like schizophrenia. Researchers have discovered a molecular link between impaired insulin signaling in the brain and schizophrenia-like behaviors in mice. The findings offer a new perspective on the psychiatric and cognitive disorders that affect patients with diabetes and suggest new strategies for treating these conditions.]]></description>
<dc:subject>diabetes schizophrenia molecular link food mood peer-reviewed research in vivo animal model</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:b3b441036fbf/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:schizophrenia"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:molecular"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:link"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:food"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:mood"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:peer-reviewed"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:in"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:vivo"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:animal"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:model"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.diabetes.org/a1c/diagnosis">
    <title>Diagnosis | ADA</title>
    <dc:date>2021-06-15T02:35:07+00:00</dc:date>
    <link>https://www.diabetes.org/a1c/diagnosis</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>diabetes diagnostic diagnosis standard threshold glycated hemoglobin A1c HbA1c prediabetes normal risk blood glucose test random fasting sugar oral tolerance ADA</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:0622d36d39d2/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diagnostic"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diagnosis"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:standard"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:threshold"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:glycated"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:hemoglobin"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:A1c"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:HbA1c"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:prediabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:normal"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:risk"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:blood"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:glucose"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:test"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:random"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:fasting"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:sugar"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:oral"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:tolerance"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:ADA"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.mayoclinic.org/diseases-conditions/diabetes/diagnosis-treatment/drc-20371451">
    <title>Diabetes - Diagnosis and treatment - Mayo Clinic</title>
    <dc:date>2021-06-15T02:11:56+00:00</dc:date>
    <link>https://www.mayoclinic.org/diseases-conditions/diabetes/diagnosis-treatment/drc-20371451</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[Glycated hemoglobin (A1C) test.
An A1C level of 6.5% or higher on two separate tests indicates that you have diabetes. An A1C between 5.7 and 6.4 % indicates prediabetes. Below 5.7 is considered normal.

Random blood sugar test. 
A blood sample will be taken at a random time. Regardless of when you last ate, a blood sugar level of 200 milligrams per deciliter (mg/dL) — 11.1 millimoles per liter (mmol/L) — or higher suggests diabetes.

Fasting blood sugar test. 
A blood sample will be taken after an overnight fast. A fasting blood sugar level less than 100 mg/dL (5.6 mmol/L) is normal. A fasting blood sugar level from 100 to 125 mg/dL (5.6 to 6.9 mmol/L) is considered prediabetes. If it's 126 mg/dL (7 mmol/L) or higher on two separate tests, you have diabetes.

Oral glucose tolerance test. For this test, you fast overnight, and the fasting blood sugar level is measured. Then you drink a sugary liquid, and blood sugar levels are tested periodically for the next two hours.
A blood sugar level less than 140 mg/dL (7.8 mmol/L) is normal. A reading of more than 200 mg/dL (11.1 mmol/L) after two hours indicates diabetes. A reading between 140 and 199 mg/dL (7.8 mmol/L and 11.0 mmol/L) indicates prediabetes.]]></description>
<dc:subject>diabetes diagnostic diagnosis standard threshold glycated hemoglobin A1c HbA1c prediabetes normal risk blood glucose test random fasting sugar oral tolerance Mayo Clinic</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:fc2a14081741/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diagnostic"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diagnosis"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:standard"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:threshold"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:glycated"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:hemoglobin"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:A1c"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:HbA1c"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:prediabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:normal"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:risk"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:blood"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:glucose"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:test"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:random"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:fasting"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:sugar"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:oral"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:tolerance"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Mayo"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Clinic"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://diabeteswise.org/check-up/#/">
    <title>Checkup Tool — DiabetesWise</title>
    <dc:date>2021-06-12T03:26:19+00:00</dc:date>
    <link>https://diabeteswise.org/check-up/#/</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>diabetes supplies tech meter pump comparison CGM sensors insulin injections MDI</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:71b6fc77ad8a/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:supplies"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:tech"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:meter"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:pump"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:comparison"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:CGM"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:sensors"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:insulin"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:injections"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:MDI"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://twitter.com/Type2andYouCDE/status/1204404950194950144/photo/1">
    <title>(400) https://twitter.com/Type2andYouCDE/status/1204404950194950144/photo/1</title>
    <dc:date>2021-05-06T07:05:29+00:00</dc:date>
    <link>https://twitter.com/Type2andYouCDE/status/1204404950194950144/photo/1</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[RT @Type2andYouCDE: There are a number of flaws in the T2D "reversal" research.... and as you look at the calorie restrictions, it's difficult not to compare to the Minnesota Starvation Experiment....
#perspective
#diabetes #TuesdayThoughts #dsma ]]></description>
<dc:subject>perspective TuesdayThoughts dsma diabetes</dc:subject>
<dc:source>https://twitter.com/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:ab514da07d37/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:perspective"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:TuesdayThoughts"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:dsma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://twicediabetes.com/cheating-lies-hcps-tell/#more-72">
    <title>Cheating &amp; Lies Health Professionals TellTwice Diabetes | Twice Diabetes</title>
    <dc:date>2021-04-11T21:46:23+00:00</dc:date>
    <link>http://twicediabetes.com/cheating-lies-hcps-tell/#more-72</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>diabetes cheating lies propaganda expectations patients providers doctors</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:d39215b918f3/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:cheating"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:lies"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:propaganda"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:expectations"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:patients"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:providers"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:doctors"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/217393">
    <title>Diabetic Ketoacidosis in Type 1 and Type 2 Diabetes Mellitus: Clinical and Biochemical Differences | Acid Base, Electrolytes, Fluids | JAMA Internal Medicine | JAMA Network</title>
    <dc:date>2021-04-06T03:57:47+00:00</dc:date>
    <link>https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/217393</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[Of 138 patients admitted for moderate-to-severe DKA, 30 had type 2 diabetes. A greater proportion of the type 2 diabetes group was Latino American or African American (P<.001). Thirty-five admissions (19.9%) were for newly diagnosed diabetes. A total of 85% of all admissions involved discontinuation of medication use, 69.2% in the type 2 group. Infections were present in 21.6% of the type 1 and 48.4% of the type 2 diabetes admissions. A total of 21% of patients with type 1 diabetes and 70% with type 2 diabetes had a body mass index greater than 27. Although the type 1 diabetes group was more acidotic (arterial pH, 7.21 ± 0.12 vs 7.27 ± 0.08; P<.001), type 2 diabetes patients required longer treatment periods (36.0 ± 11.6 vs 28.9 ± 8.9 hours, P = .01) to achieve ketone-free urine. Complications from therapy were uncommon.]]></description>
<dc:subject>diabetic ketoacidosis DKA diagnosis type 1 diabetes T1D trends incidence prevalence peer-reviewed research hospitalization human retrospective cohort vulnerability susceptibility correlation in vivo situ 2 T2D emergency crisis</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:5fe627671df5/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetic"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:ketoacidosis"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:DKA"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diagnosis"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:1"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T1D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:trends"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:incidence"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:prevalence"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:peer-reviewed"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:hospitalization"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:human"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:retrospective"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:cohort"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:vulnerability"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:susceptibility"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:correlation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:in"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:vivo"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:situ"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:2"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T2D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:emergency"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:crisis"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.cdc.gov/mmwr/volumes/67/wr/mm6712a3.htm">
    <title>Trends in Diabetic Ketoacidosis Hospitalizations and In-Hospital Mortality — United States, 2000–2014 | MMWR</title>
    <dc:date>2021-04-06T03:40:18+00:00</dc:date>
    <link>https://www.cdc.gov/mmwr/volumes/67/wr/mm6712a3.htm</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[iabetic ketoacidosis (DKA) is a life-threatening complication of diabetes, a disease that affects approximately 30 million persons in the United States. DKA is more common among persons with type 1 diabetes.

What is added by this report?

After a slight decline during 2000–2009, hospitalizations for DKA increased in the United States during 2009–2014 among all age groups and were highest among persons aged <45 years. Concurrently, in-hospital case-fatality rates among persons with DKA consistently decreased from 2000 to 2014.

What are the implications for public health practice?

DKA is a life-threatening but avoidable complication of diabetes. Prevention measures, such as diabetes self-management education, might help reverse the increasing trend in DKA, especially in persons aged <45 years who have the highest DKA rates.]]></description>
<dc:subject>diabetic ketoacidosis DKA diagnosis type 1 diabetes T1D age trends incidence prevalence peer-reviewed research hospitalization human retrospective cohort vulnerability susceptibility correlation emergency crisis</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:ad19c098ac31/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetic"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:ketoacidosis"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:DKA"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diagnosis"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:1"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T1D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:age"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:trends"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:incidence"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:prevalence"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:peer-reviewed"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:hospitalization"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:human"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:retrospective"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:cohort"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:vulnerability"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:susceptibility"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:correlation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:emergency"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:crisis"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357617/">
    <title>Diabetic ketoacidosis at the onset of Type 1 diabetes in young children</title>
    <dc:date>2021-04-05T04:07:31+00:00</dc:date>
    <link>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357617/</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>diabetic ketoacidosis DKA diagnosis type 1 diabetes T1D Italy children peer-reviewed research in vivo situ hospitalization human retrospective cohort insurance correlation emergency crisis</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:26dac5c5ece7/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetic"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:ketoacidosis"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:DKA"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diagnosis"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:1"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T1D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Italy"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:children"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:peer-reviewed"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:in"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:vivo"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:situ"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:hospitalization"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:human"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:retrospective"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:cohort"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:insurance"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:correlation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:emergency"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:crisis"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3215499/">
    <title>Frequency of Ketoacidosis in Newly Diagnosed Type 1 Diabetic Children</title>
    <dc:date>2021-04-05T04:05:19+00:00</dc:date>
    <link>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3215499/</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>diabetic ketoacidosis DKA diagnosis type 1 diabetes T1D Iran children peer-reviewed research in vivo situ hospitalization human retrospective cohort insurance correlation emergency crisis</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:64679032977c/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetic"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:ketoacidosis"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:DKA"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diagnosis"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:1"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T1D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Iran"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:children"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:peer-reviewed"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:in"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:vivo"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:situ"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:hospitalization"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:human"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:retrospective"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:cohort"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:insurance"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:correlation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:emergency"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:crisis"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://link.springer.com/article/10.1007/s00125-012-2690-2">
    <title>Variation between countries in the frequency of diabetic ketoacidosis at first presentation of type 1 diabetes in children: a systematic review | SpringerLink</title>
    <dc:date>2021-04-05T04:04:07+00:00</dc:date>
    <link>https://link.springer.com/article/10.1007/s00125-012-2690-2</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>diabetic ketoacidosis DKA diagnosis type 1 diabetes T1D international comparison systematic review children peer-reviewed research in vivo situ hospitalization human retrospective cohort insurance correlation emergency crisis</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:ba27906b807d/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetic"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:ketoacidosis"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:DKA"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diagnosis"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:1"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T1D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:international"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:comparison"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:systematic"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:review"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:children"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:peer-reviewed"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:in"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:vivo"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:situ"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:hospitalization"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:human"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:retrospective"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:cohort"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:insurance"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:correlation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:emergency"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:crisis"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://care.diabetesjournals.org/content/43/1/117">
    <title>Diabetic Ketoacidosis at Diagnosis of Type 1 Diabetes in Colorado Children, 2010–2017 | Diabetes Care</title>
    <dc:date>2021-04-05T04:02:19+00:00</dc:date>
    <link>https://care.diabetesjournals.org/content/43/1/117</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>diabetic ketoacidosis DKA diagnosis type 1 diabetes T1D Colorado children peer-reviewed research in vivo situ hospitalization human retrospective cohort nsurance correlation emergency crisis</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:54ec3e0057dc/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetic"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:ketoacidosis"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:DKA"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diagnosis"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:1"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T1D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Colorado"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:children"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:peer-reviewed"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:in"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:vivo"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:situ"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:hospitalization"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:human"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:retrospective"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:cohort"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:nsurance"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:correlation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:emergency"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:crisis"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://macrofour.com/the-cure-for-diabetes-delivered">
    <title>Type 2 Diabetes: Beyond Remission to a Cure - Macro Four</title>
    <dc:date>2021-03-28T02:57:00+00:00</dc:date>
    <link>http://macrofour.com/the-cure-for-diabetes-delivered</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>type 2 diabetes T2D remission data n=1 trial human clinical in vivo situ diet</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:a727ce765276/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:2"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T2D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:remission"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:data"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:n=1"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:trial"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:human"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:clinical"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:in"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:vivo"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:situ"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diet"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://link.springer.com/article/10.1007/s00125-020-05253-x#Sec4">
    <title>An atlas on risk factors for type 2 diabetes: a wide-angled Mendelian randomisation study | SpringerLink</title>
    <dc:date>2020-10-15T06:30:28+00:00</dc:date>
    <link>https://link.springer.com/article/10.1007/s00125-020-05253-x#Sec4</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>diabetes type 2 risk factors T2D correlation peer-reviewed research epidemiology etiology</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:5ebc949a473c/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:2"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:risk"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:factors"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T2D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:correlation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:peer-reviewed"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:epidemiology"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:etiology"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://care.diabetesjournals.org/content/28/11/2756">
    <title>Increased Mortality Risks of Pre-Diabetes (Impaired Fasting Glucose) in Taiwan | Diabetes Care</title>
    <dc:date>2020-09-27T17:44:12+00:00</dc:date>
    <link>https://care.diabetesjournals.org/content/28/11/2756</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[RESULTS—FBG ≥110 mg/dl was associated with increased mortality risks for all causes, cardiovascular diseases (CVD), and diabetes. IFG, when defined as 110–125 mg/dl, was associated with a significant increase for CVD and/or diabetes mortality. These mortality risks remained elevated when known CVD risk factors were adjusted for. The IFG group shared risk factor characteristics more with the FBG ≥126 mg/dl group than with the FBG <110 mg/dl group. When IFG was defined as 100–125 mg/dl, the number of subjects quadrupled, but mortality risks diminished substantially because of the inclusion of 100–109 mg/dl group. The lowest FBG group, 50–75 mg/dl, had a significant 2-fold risk from all causes.

CONCLUSIONS—There was an overall J-shaped relationship between all-cause mortality and FBG. IFG, when defined as 110–125 mg/dl, is an independent risk factor and should be aggressively treated as a disease because its subsequent mortality risks for CVD and diabetes were significantly increased. The newly defined IFG at 100–125 mg/dl did not have the predictive power for later increases in CVD or diabetes mortality.]]></description>
<dc:subject>FBG IFG impaired fasting blood glucose mortality CVD cardiovascular disease risk threshold diagnostic standards prediabetes diabetes all-cause peer-reviewed research in vivo human cohort study</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:117b43629584/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:FBG"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:IFG"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:impaired"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:fasting"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:blood"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:glucose"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:mortality"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:CVD"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:cardiovascular"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:disease"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:risk"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:threshold"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diagnostic"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:standards"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:prediabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:all-cause"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:peer-reviewed"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:in"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:vivo"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:human"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:cohort"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:study"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.pbs.org/wgbh/blood-sugar-rising/home/watch/">
    <title>Blood Sugar Rising - Watch</title>
    <dc:date>2020-09-23T02:30:32+00:00</dc:date>
    <link>https://www.pbs.org/wgbh/blood-sugar-rising/home/watch/</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>diabetes education documentary PBS video</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:b29ab4ad98c7/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:education"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:documentary"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:PBS"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:video"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://professional.diabetes.org/content-page/practice-guidelines-resources">
    <title>Practice Guidelines Resources | American Diabetes Association</title>
    <dc:date>2020-09-22T03:57:54+00:00</dc:date>
    <link>https://professional.diabetes.org/content-page/practice-guidelines-resources</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>diabetes standard of care ADA American Association</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:44da436b6a33/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:standard"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:of"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:care"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:ADA"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:American"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Association"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.diabetesselfmanagement.com/blog/vitamin-d-pills-type-2-diabetes-progression-study/">
    <title>Vitamin D Pills May Slow Type 2 Diabetes Progression: Study - Diabetes Self-Management</title>
    <dc:date>2020-09-22T02:48:37+00:00</dc:date>
    <link>https://www.diabetesselfmanagement.com/blog/vitamin-d-pills-type-2-diabetes-progression-study/</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>vitamin D diabetes progression</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:ade4dd517998/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:vitamin"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:progression"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.cdc.gov/diabetes/programs/stateandlocal/resources/dsmes-technical-assistance-guide.html">
    <title>Diabetes Self-Management Education and Support (DSMES) Technical Assistance Guide</title>
    <dc:date>2020-09-20T14:25:12+00:00</dc:date>
    <link>https://www.cdc.gov/diabetes/programs/stateandlocal/resources/dsmes-technical-assistance-guide.html</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>Standards Diabetes Self-Management Education and Support DSMES CDC</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:5b325ebc952f/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Standards"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Self-Management"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Education"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:and"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Support"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:DSMES"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:CDC"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.diabeteseducator.org/practice/practice-documents/national-standards-for-dsmes">
    <title>National Standards for DSMES</title>
    <dc:date>2020-09-20T14:23:29+00:00</dc:date>
    <link>https://www.diabeteseducator.org/practice/practice-documents/national-standards-for-dsmes</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[Standards for Diabetes Self-Management Education and Support]]></description>
<dc:subject>Standards Diabetes Self-Management Education and Support DSMES ADCES</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:a3e9e5af8770/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Standards"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Self-Management"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Education"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:and"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Support"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:DSMES"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:ADCES"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://scienceblogs.com/deanscorner/2011/03/09/diabetes-belt-fast-food-belt">
    <title>&quot;Diabetes Belt&quot; = &quot;Fast Food Belt&quot;? | ScienceBlogs</title>
    <dc:date>2020-07-19T00:15:50+00:00</dc:date>
    <link>https://scienceblogs.com/deanscorner/2011/03/09/diabetes-belt-fast-food-belt</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[The US Centers for Disease Control and Prevention (CDC) has just released a high resolution map "Percentage of Adults with Diagnosed Diabetes"...
Scientific American (March 8, 2011) points out: 
"[Diabetes costs the US some $174 billion a year. Local public health agencies charged with managing and preventing diabetes have lacked data to drive the funding] to rein in rates in their areas. 
"[Drilling down to the county level reveals] wide disparities within states and striking national patterns. ['Diabetes belt' counties are in] Alabama, Arkansas, Florida, Georgia, Kentucky, Louisiana, Mississippi, North Carolina, Ohio, Pennsylvania, South Carolina, Tennessee, Texas, Virginia and West Virginia[—]unevenly distributed among those states...ranging from a few in Ohio and Texas to the majority of Alabama's counties—and every one in Mississippi." 
[Might there be] a correlation of incidence of diabetes and fast food restaurants, given the clear link between type 2 diabetes and obesity[?]]]></description>
<dc:subject>maps mapping visualization diabetes food religion fast diet earnest criticism science demographics culture correlation nutrition etiology SDoH social determinants of health poverty belt malnutrition</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:69bbd2a092cc/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:maps"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:mapping"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:visualization"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:food"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:religion"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:fast"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diet"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:earnest"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:criticism"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:science"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:demographics"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:culture"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:correlation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:nutrition"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:etiology"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:SDoH"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:social"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:determinants"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:of"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:health"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:poverty"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:belt"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:malnutrition"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://twitter.com/fallabel/status/1271546651031658496?s=12">
    <title>twitter.com</title>
    <dc:date>2020-06-13T13:32:41+00:00</dc:date>
    <link>https://twitter.com/fallabel/status/1271546651031658496?s=12</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>T2D 2 infusion 1 self sensor care diabetes INSULIN T1D irritation skin typ pump site rash</dc:subject>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:0c807a14cba2/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T2D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:2"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:infusion"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:1"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:self"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:sensor"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:care"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:INSULIN"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T1D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:irritation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:skin"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:typ"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:pump"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:site"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:rash"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://sugarbeat.com/">
    <title>SugarBEAT | non-invasive glucose monitoring</title>
    <dc:date>2020-04-13T03:24:32+00:00</dc:date>
    <link>https://sugarbeat.com/</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[sugarBEAT]]></description>
<dc:subject>diabetes tech CGM type 2 T2D 1 prediabetes T1D</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:49a90f1ef51d/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:tech"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:CGM"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:2"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T2D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:1"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:prediabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T1D"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.medpagetoday.com/endocrinology/type1diabetes/82755?xid=nl_mpt_DHE_2019-10-16&amp;eun=g894600d0r">
    <title>Durable Glycemic Benefits With Islet Transplantation in T1D | MedPage Today</title>
    <dc:date>2020-04-04T15:18:28+00:00</dc:date>
    <link>https://www.medpagetoday.com/endocrinology/type1diabetes/82755?xid=nl_mpt_DHE_2019-10-16&amp;eun=g894600d0r</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[Ten-year outcomes for 28 patients who underwent allogeneic islet transplantation with the Edmonton protocol showed 28% free from insulin and maintaining HbA1c levels of ≤6.5%, reported Marie-Christine Vantyghem, MD, PhD of the University of Lille in France, and colleagues.

Nearly 40% of these patients were able to achieve insulin independence with A1c ≤6.5% -- the study's primary endpoint -- only 5 years after islet transplantation, they wrote in Diabetes Care.]]></description>
<dc:subject>islet transplantation transplant pancreas T1D type 1 diabetes glycemic control blood glucose Edmonton protocol hypoglycemia unawareness kidney risk</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:29fec18ec123/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:islet"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:transplantation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:transplant"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:pancreas"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T1D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:1"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:glycemic"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:control"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:blood"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:glucose"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Edmonton"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:protocol"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:hypoglycemia"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:unawareness"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:kidney"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:risk"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://well.blogs.nytimes.com/2013/07/12/blaming-the-patient-then-asking-forgiveness/">
    <title>Blaming the Patient, Then Asking Forgiveness - The New York Times</title>
    <dc:date>2020-03-08T03:39:53+00:00</dc:date>
    <link>https://well.blogs.nytimes.com/2013/07/12/blaming-the-patient-then-asking-forgiveness/</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[Dr. Attia’s insight was informed, in part, by the startling discovery a few years ago that despite paying close attention to his diet and exercising frequently, often for hours at a time, he had developed metabolic syndrome, a precursor to Type 2 diabetes. He had made all the right lifestyle choices, he thought, and yet he was overweight and on a fast track toward obesity and diabetes.

The revelation, Dr. Attia says in his talk, forced him to make drastic changes in his life. And it led him to question whether the conventional wisdom about obesity that has prevailed for decades may be fundamentally wrong. Obesity itself may not be the cause of disease, he suggests, but one symptom of an underlying metabolic problem.

“We have this paradigm that says that if you eat too much, you don’t exercise enough, you get diabetes and you die,” he said. “With that belief in that paradigm, we’ve been treating people for 40 years, and things are getting worse dramatically.”]]></description>
<dc:subject>Peter Attia etiology diabetes body fat obesity chicken-and-egg cause TED</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:88ab2d987fdd/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Peter"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Attia"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:etiology"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:body"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:fat"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:obesity"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:chicken-and-egg"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:cause"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:TED"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://sternspeakers.com/news/happens-experts-err-dr-peter-attias-ted-talk-goes-viral-find/">
    <title>What Happens When Experts Err? Dr. Peter Attia's TED Talk Goes Viral. Find Out Why. | Stern Speakers</title>
    <dc:date>2020-03-08T03:36:36+00:00</dc:date>
    <link>https://sternspeakers.com/news/happens-experts-err-dr-peter-attias-ted-talk-goes-viral-find/</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[As a young surgeon, he didn’t doubt the “settled science” that obesity caused diabetes. Of a young, overweight, diabetic woman whose foot he amputated, he thought: it’s her fault. If she had cared more and ate less, she wouldn’t be on this operating table. Dr. Attia confessed his mightier-than-thou judgment in an emotional and highly personal TED talk that has since gone viral. Clearly his message has hit a nerve.
Dr. Attia now knows he was wrong – and he’s determined to make it right. After facing – and winning – his own crisis with diabetes’ precursor metabolic syndrome several years ago, he’s questioning everything and rallying the medical community to do the same. What if obesity is a symptom of diabetes, a disguise for a much deeper problem? Then we’re fighting the wrong war and the implications are profound. After all, if conventional wisdom failed Attia – a doctor and a physically fit endurance athlete who “did everything right” – it’s likely failing millions more, simply because we’re relying on misguided medical “truths” about chronic diseases.]]></description>
<dc:subject>Peter Attia etiology diabetes body fat obesity chicken-and-egg cause TED</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:3ff90f843f55/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Peter"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Attia"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:etiology"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:body"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:fat"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:obesity"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:chicken-and-egg"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:cause"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:TED"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.bmj.com/content/368/bmj.l6775/rapid-responses">
    <title>Losing weight following diagnosis of type 2 diabetes boosts chance of remission | The BMJ</title>
    <dc:date>2020-02-05T00:34:45+00:00</dc:date>
    <link>https://www.bmj.com/content/368/bmj.l6775/rapid-responses</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>weight fat management loss body type 2 diabetes remission T2D peer-reviewed research clinical in vivo human exercise behavioral intervention</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:19fae1c1537b/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:weight"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:fat"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:management"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:loss"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:body"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:2"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:remission"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T2D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:peer-reviewed"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:clinical"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:in"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:vivo"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:human"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:exercise"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:behavioral"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:intervention"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.nature.com/articles/ejcn201539/">
    <title>Metabolic and physiologic effects from consuming a hunter-gatherer (Paleolithic)-type diet in type 2 diabetes | European Journal of Clinical Nutrition</title>
    <dc:date>2019-12-30T03:27:53+00:00</dc:date>
    <link>https://www.nature.com/articles/ejcn201539/</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[Both groups had improvements in metabolic measures, but the Paleo diet group had greater benefits on glucose control and lipid profiles. Also, on the Paleo diet, the most insulin-resistant subjects had a significant improvement in insulin sensitivity (r=0.40, P=0.02), but no such effect was seen in the most insulin-resistant subjects on the ADA diet (r= 0.39, P=0.3).

Conclusions:
Even short-term consumption of a Paleolithic-type diet improved glucose control and lipid profiles in people with type 2 diabetes compared with a conventional diet containing moderate salt intake, low-fat dairy, whole grains and legumes.]]></description>
<dc:subject>Paleo diet grain legumes dairy RCT random controlled trial human in vivo situ clinical research lipids hyperlipidemia management blood glucose insulin resistance sensitivity ADA diabetes type 2 T2D</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:14f5a3ef80a5/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Paleo"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diet"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:grain"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:legumes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:dairy"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:RCT"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:random"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:controlled"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:trial"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:human"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:in"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:vivo"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:situ"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:clinical"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:lipids"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:hyperlipidemia"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:management"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:blood"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:glucose"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:insulin"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:resistance"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:sensitivity"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:ADA"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:2"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T2D"/>
</rdf:Bag></taxo:topics>
</item>
</rdf:RDF>